Ischemia-reperfusion injury in rat steatotic liver is dependent on NFκB P65 activation

Transplant Immunology

Volumn 26, Issue 4, 2012, Pages 201-206

  Ramachandran, Sabarinathan ^a   Liaw, Jane M ^a   Jia, Jianluo ^a   Glasgow, Sean C ^a   Liu, Wei ^a   Csontos, Krista ^a   Upadhya, G A ^a   Mohanakumar, T ^a   Chapman, William C ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bortezomib; Hepatic steatosis; I R injury; Liver transplantation; Marginal graft; NF B; Obese; PS 341

Indexed keywords

ALANINE AMINOTRANSFERASE; BORTEZOMIB; INTERLEUKIN 1BETA; MACROPHAGE INFLAMMATORY PROTEIN 2; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE EXACERBATION; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; FATTY LIVER; GEL MOBILITY SHIFT ASSAY; HISTOPATHOLOGY; LIVER INJURY; LIVER ISCHEMIA; LIVER TRANSPLANTATION; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY;

ANIMALS; BORONIC ACIDS; CHEMOKINE CXCL2; DISEASE MODELS, ANIMAL; FATTY LIVER; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-1BETA; LIVER; PROTEASOME ENDOPEPTIDASE COMPLEX; PYRAZINES; RATS; RATS, ZUCKER; REPERFUSION INJURY; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84862787393     PISSN: 09663274     EISSN: 18785492     Source Type: Journal    
DOI: 10.1016/j.trim.2012.01.001     Document Type: Article

References (37)

1. Adam R., Bismuth H., Diamond T., Ducot B., Morino M., Astarcioglu I., et al. Effect of extended cold ischaemia with UW solution on graft function after liver transplantation. Lancet 1992, 340:1373-1376.
2. Adam R., Reynes M., Johann M., Morino M., Astarcioglu I., Kafetzis I., et al. The outcome of steatotic grafts in liver transplantation. Transplant Proc 1991, 23:1538-1540.
3. Marsman W.A., Wiesner R.H., Rodriguez L., Batts K.P., Porayko M.K., Hay J.E., et al. Use of fatty donor liver is associated with diminished early patient and graft survival. Transplantation 1996, 62:1246-1251.
4. Todo S., Demetris A.J., Makowka L., Teperman L., Podesta L., Shaver T., et al. Primary nonfunction of hepatic allografts with preexisting fatty infiltration. Transplantation 1989, 47:903-905.
5. D'Alessandro A.M., Kalayoglu M., Sollinger H.W., Hoffmann R.M., Reed A., Knechtle S.J., et al. The predictive value of donor liver biopsies on the development of primary nonfunction after orthotopic liver transplantation. Transplant Proc 1991, 23:1536-1537.
6. Funaki H., Shimizu K., Harada S., Tsuyama H., Fushida S., Tani T., et al. Essential role for nuclear factor kappaB in ischemic preconditioning for ischemia-reperfusion injury of the mouse liver. Transplantation 2002, 74:551-556.
7. Teoh N., Field J., Sutton J., Farrell G. Dual role of tumor necrosis factor-alpha in hepatic ischemia-reperfusion injury: studies in tumor necrosis factor-alpha gene knockout mice. Hepatology 2004, 39:412-421.
8. Selzner M., Rudiger H.A., Sindram D., Madden J., Clavien P.A. Mechanisms of ischemic injury are different in the steatotic and normal rat liver. Hepatology 2000, 32:1280-1288.
9. Argiles J.M. The obese Zucker rat: a choice for fat metabolism 1968-1988: twenty years of research on the insights of the Zucker mutation. Prog Lipid Res 1989, 28:53-66.
10. Bray G.A. The Zucker-fatty rat: a review. Fed Proc 1977, 36:148-153.
11. Chua S.C., Chung W.K., Wu-Peng X.S., Zhang Y., Liu S.M., Tartaglia L., et al. Phenotypes of mouse diabetes and rat fatty due to mutations in the OB (leptin) receptor. Science 1996, 271:994-996.
12. White B.D., Martin R.J. Evidence for a central mechanism of obesity in the Zucker rat: role of neuropeptide Y and leptin. Proc Soc Exp Biol Med 1997, 214:222-232.
13. Kamada N., Calne R.Y. A surgical experience with five hundred thirty liver transplants in the rat. Surgery 1983, 93:64-69.
14. Camargo C.A., Madden J.F., Gao W., Selvan R.S., Clavien P.A. Interleukin-6 protects liver against warm ischemia/reperfusion injury and promotes hepatocyte proliferation in the rodent. Hepatology 1997, 26:1513-1520.
15. Behrns K.E., Tsiotos G.G., DeSouza N.F., Krishna M.K., Ludwig J., Nagorney D.M. Hepatic steatosis as a potential risk factor for major hepatic resection. J Gastrointest Surg 1998, 2:292-298.
16. Selzner N., Selzner M., Jochum W., Amann-Vesti B., Graf R., Clavien P.A. Mouse livers with macrosteatosis are more susceptible to normothermic ischemic injury than those with microsteatosis. J Hepatol 2006, 44:694-701.
17. Strasberg S.M., Howard T.K., Molmenti E.P., Hertl M. Selecting the donor liver: risk factors for poor function after orthotopic liver transplantation. Hepatology 1994, 20:829-838.
18. Azoulay D., Eshkenazy R., Andreani P., Castaing D., Adam R., Ichai P., et al. In situ hypothermic perfusion of the liver versus standard total vascular exclusion for complex liver resection. Ann Surg 2005, 241:277-285.
19. Carrasco-Chaumel E., Rosello-Catafau J., Bartrons R., Franco-Gou R., Xaus C., Casillas A., et al. Adenosine monophosphate-activated protein kinase and nitric oxide in rat steatotic liver transplantation. J Hepatol 2005, 43:997-1006.
20. Lentsch A.B., Kato A., Yoshidome H., McMasters K.M., Edwards M.J. Inflammatory mechanisms and therapeutic strategies for warm hepatic ischemia/reperfusion injury. Hepatology 2000, 32:169-173.
21. Malhi H., Gores G.J., Lemasters J.J. Apoptosis and necrosis in the liver: a tale of two deaths?. Hepatology 2006, 43:S31-S44.
22. Ghosh S., Karin M. Missing pieces in the NF-kappaB puzzle. Cell 2002, 109:S81-S96. Suppl.
23. Luedde T., Trautwein C. Intracellular survival pathways in the liver. Liver Int 2006, 26:1163-1174.
24. Perkins N.D., Gilmore T.D. Good cop, bad cop: the different faces of NF-kappaB. Cell Death Differ 2006, 13:759-772.
25. Karin M., Lin A. NF-kappaB at the crossroads of life and death. Nat Immunol 2002, 3:221-227.
26. Rudiger H.A., Clavien P.A. Tumor necrosis factor alpha, but not Fas, mediates hepatocellular apoptosis in the murine ischemic liver. Gastroenterology 2002, 122:202-210.
27. Delhase M., Hayakawa M., Chen Y., Karin M. Positive and negative regulation of IkappaB kinase activity through IKKbeta subunit phosphorylation. Science 1999, 284:309-313.
28. Farhood A., McGuire G.M., Manning A.M., Miyasaka M., Smith C.W., Jaeschke H. Intercellular adhesion molecule 1 (ICAM-1) expression and its role in neutrophil-induced ischemia-reperfusion injury in rat liver. J Leukoc Biol 1995, 57:368-374.
29. Jaeschke H., Farhood A. Neutrophil and Kupffer cell-induced oxidant stress and ischemia-reperfusion injury in rat liver. Am J Physiol 1991, 260:G355-G362.
30. Jaeschke H., Smith C.W. Mechanisms of neutrophil-induced parenchymal cell injury. J Leukoc Biol 1997, 61:647-653.
31. Campbell K.J., Perkins N.D. Post-translational modification of RelA(p65) NF-kappaB. Biochem Soc Trans 2004, 32:1087-1089.
32. Anan A., Baskin-Bey E.S., Isomoto H., Mott J.L., Bronk S.F., Albrecht J.H., et al. Proteasome inhibition attenuates hepatic injury in the bile duct-ligated mouse. Am J Physiol Gastrointest Liver Physiol 2006, 291:G709-G716.
33. Matsui N., Kasajima K., Hada M., Nagata T., Senga N., Yasui Y., et al. Inhibition of NF-kappaB activation during ischemia reduces hepatic ischemia/reperfusion injury in rats. J Toxicol Sci 2005, 30:103-110.
34. McDonald M.C., Mota-Filipe H., Paul A., Cuzzocrea S., Abdelrahman M., Harwood S., et al. Calpain inhibitor I reduces the activation of nuclear factor-kappaB and organ injury/dysfunction in hemorrhagic shock. FASEB J 2001, 15:171-186.
35. Suetsugu H., Iimuro Y., Uehara T., Nishio T., Harada N., Yoshida M., et al. Nuclear factor {kappa}B inactivation in the rat liver ameliorates short term total warm ischaemia/reperfusion injury. Gut 2005, 54:835-842.
36. Karin M., Ben-Neriah Y. Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu Rev Immunol 2000, 18:621-663.
37. Takahashi Y., Ganster R.W., Gambotto A., Shao L., Kaizu T., Wu T., et al. Role of NF-kappaB on liver cold ischemia-reperfusion injury. Am J Physiol Gastrointest Liver Physiol 2002, 283:G1175-G1184.